Although the estimated number of HIV cases in the United States (US) has remained the same over the last decade, there is increasing evidence of an epidemic resurgence. New HIV preventive intervention approaches that target HIV infected individuals are being strongly advocated. The current project outlines a unique, multifaceted, and collaborative approach to evaluating HIV preventive interventions that are expected to have an impact at the population level, such as would be expected from interventions that are implemented with HIV infected individuals. One study provides strong evidence that interventions implemented with HIV infected individuals not only have an impact at the population level, but can be evaluated at that level as well. The current project proposes the development of evaluation tool that relies on establish surveillance methodology and is in preparation for an intervention conducted with HIV infected individuals. The evaluation tool will be used to provide baseline data on population herpes simplex virus-2 (HSV-2)/HIV co-infection, as well as to evaluate a future HIV preventive intervention that provides HSV-2 suppressive therapy to HSV-2/HIV co-infected individuals. To that end, we propose the following specific aims:
Aim 1 : An evaluation tool or sentinel will be developed to assess HSV-2/HIV co-infection incidence and prevalence and will contain basic demographic information; the validity and feasibility of the evaluation tool will be assessed through a pilot study conducted during the first quarter of data collection.
Aim 2 : To explore the HIV transmission dynamics associated with HSV-2 co-infection, comparable analyses will be conducted (a) with the evaluation tool data set, (b) with the parent study data set, and (c) comparing the results between the two data sets.
Aim 3 : The feasibility of transferring and adapting the methodology and technology for ongoing sentinel surveillance in this community as an academic/public health collaborative effort will be assessed. Finally, the methodology developed for this evaluation tool may be adapted for use in the evaluation of social network interventions, community level interventions, and other interventions implemented with individuals expected to have an outcome at the population level. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA014523-04S1
Application #
6800291
Study Section
Special Emphasis Panel (ZRG1-BSPH (02))
Program Officer
Lambert, Elizabeth
Project Start
2001-05-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2006-04-30
Support Year
4
Fiscal Year
2004
Total Cost
$762,292
Indirect Cost
Name
Columbia University (N.Y.)
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Miller, Maureen; Liao, Yuyan; Wagner, Meghan et al. (2008) HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis 35:696-702
Miller, Maureen; Liao, Yuyan; Gomez, Anu Manchikanti et al. (2008) Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs. J Infect Dis 197:503-9
Miller, M; Korves, C T; Fernandez, T (2007) The social epidemiology of HIV transmission among African American women who use drugs and their social network members. AIDS Care 19:858-65
Miller, Maureen; Serner, Malin; Wagner, Meghan (2005) Sexual diversity among black men who have sex with men in an inner-city community. J Urban Health 82:i26-34
Roche, Brenda; Neaigus, Alan; Miller, Maureen (2005) Street smarts and urban myths: women, sex work, and the role of storytelling in risk reduction and rationalization. Med Anthropol Q 19:149-70
Cespedes, Christian; Said-Salim, Battouli; Miller, Maureen et al. (2005) The clonality of Staphylococcus aureus nasal carriage. J Infect Dis 191:444-52
Miller, Maureen; Mella, Inge; Moi, Harald et al. (2003) HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J Acquir Immune Defic Syndr 33:373-9
Miller, Maureen (2003) The dynamics of substance use and sex networks in HIV transmission. J Urban Health 80:iii88-96
Miller, M; Cespedes, C; Vavagiakis, P et al. (2003) Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 22:463-9
Lowy, Franklin D; Miller, Maureen (2002) New methods to investigate infectious disease transmission and pathogenesis--Staphylococcus aureus disease in drug users. Lancet Infect Dis 2:605-12